SCV
Sands Capital Ventures Portfolio holdings
AUM
$508M
1-Year Est. Return
48.12%
1 Year Est. Return
+48.12%
AUM
$409M
AUM Growth
-$50.8M
(-11%)
Holding
22
Top Buys
| 1 | +$38M | |
| 2 | +$2.1M | |
| 3 | +$2M | |
| 4 |
Nu Holdings
NU
|
+$1.47M |
| 5 |
monday.com
MNDY
|
+$396K |
Top Sells
| 1 | +$12.2M | |
| 2 | +$4.87M | |
| 3 | +$1.78M | |
| 4 |
Snowflake
SNOW
|
+$1.78M |
| 5 |
Klaviyo
KVYO
|
+$822K |
Sector Composition
| 1 | Technology | 38.69% |
| 2 | Healthcare | 21.82% |
| 3 | Consumer Discretionary | 21.54% |
| 4 | Financials | 17.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Klaviyo
KVYO
$7.96B
| $104M | 25.48% |
3,443,515
-27,179
|
|
||
|
2
Nu Holdings
NU
$77.9B
| $73.4M | 17.94% |
7,164,355
+143,196
|
|
||
3
DoorDash
DASH
$103B
| $69.6M | 17.02% |
380,704
-26,639
|
|
||
|
BBNX
4
Beta Bionics
BBNX
$1.22B
| $38M | 9.29% |
+3,103,782
|
|
||
5
Inhibikase Therapeutics
IKT
$119M
| $24M | 5.86% |
10,950,000
|
|
||
6
Coupang
CPNG
$58.3B
| $18.5M | 4.52% |
843,476
-81,236
|
|
||
|
7
monday.com
MNDY
$10.6B
| $12.1M | 2.97% |
49,908
+1,630
|
|
||
8
Datadog
DDOG
$56.5B
| $11.7M | 2.86% |
117,930
+20,142
|
|
||
9
Samsara
IOT
$23.2B
| $9.71M | 2.38% |
253,432
+54,742
|
|
||
10
Tarsus Pharmaceuticals
TARS
$2.95B
| $8.73M | 2.14% |
170,000
|
|
||
11
Toast
TOST
$20.8B
| $6.99M | 1.71% |
210,611
-20,919
|
|
||
12
CrowdStrike
CRWD
$139B
| $5.49M | 1.34% |
15,560
-1,540
|
|
||
13
Acrivon Therapeutics
ACRV
$73.3M
| $4.31M | 1.05% |
2,122,605
|
|
||
14
10x Genomics
TXG
$1.71B
| $4.21M | 1.03% |
481,770
|
|
||
15
UiPath
PATH
$8.43B
| $4.08M | 1% |
395,855
-1,188,822
|
|
||
|
16
Snowflake
SNOW
$93.9B
| $3.92M | 0.96% |
26,828
-12,179
|
|
||
17
Acumen Pharmaceuticals
ABOS
$132M
| $3.76M | 0.92% |
3,417,075
|
|
||
|
BIOA
18
BioAge Labs
BIOA
$266M
| $2.96M | 0.72% |
786,353
|
|
||
19
Candel Therapeutics
CADL
$287M
| $2.29M | 0.56% |
405,837
|
|
||
20
Taysha Gene Therapies
TSHA
$1.22B
| $1.01M | 0.25% |
724,873
|
|
||
21
908 Devices
MASS
$286M
| – | – |
-237,258
|
|
||
|
SPRB
22
Spruce Biosciences
SPRB
$59M
| – | – |
-715,817
|
|